Related Experiment Video

Updated: Jun 23, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma

I Aladzsity1, M Kovács, A Semsei

  • 13rd Department of Internal Medicine, Semmelweis University, 1125 Budapest, Hungary.

Leukemia Research
|May 2, 2009
PubMed

Insights

This study investigated genetic variations in interleukin 6 (IL6) and IL6 receptor (IL6R) in myelodysplastic syndrome (MDS) and multiple myeloma (MM) patients. No significant differences in IL6 gene polymorphisms were found between patients and controls, suggesting other factors influence elevated IL6 levels.

Area of Science:

  • Immunology
  • Genetics
  • Geriatric Medicine

Background:

  • Elevated serum interleukin 6 (IL6) levels are observed in myelodysplastic syndrome (MDS) and multiple myeloma (MM), common in the elderly.
  • The precise causes for elevated IL6 in MDS and MM are not fully understood, prompting investigation into genetic factors.

Purpose of the Study:

  • To investigate the association between IL6 gene promoter (-174 G>C) and IL6 receptor (IL6R; Asp358Ala) polymorphisms and the risk of MDS and MM.
  • To explore potential genetic underpinnings for elevated IL6 serum levels in these hematological malignancies.

Main Methods:

  • Genotyping of the IL6 -174 G>C promoter polymorphism and the IL6R Asp358Ala polymorphism was performed.
  • Blood samples from 102 MDS patients, 100 MM patients, and 99 age- and sex-matched controls were analyzed.

Main Results:

  • No statistically significant differences in the frequencies of the studied IL6 promoter and IL6R polymorphisms were observed between MDS patients, MM patients, and healthy controls.
  • These findings indicate that the investigated polymorphisms are unlikely to be the primary cause of elevated IL6 levels in MDS and MM.

Conclusions:

  • The elevated serum IL6 levels in MDS and MM are likely due to mechanisms other than the investigated IL6 and IL6R gene polymorphisms.
  • Further research is warranted to explore alternative pathways, potentially involving signal transduction in iron metabolism, in the pathogenesis of MDS and MM in the elderly.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...